1,823 followers
New chapter in the Acute Myeloid Leukemia anthology/journal discusses future R&D in the space, including glasdegib $PFE, CC-486 $BMY, quizartinib (FLT3), APR-246 (mutant TP53) $APRE, and idasanutlin (MDM2). Other MDM2 bio - $RAIN (via Daiichi & $R